194 related articles for article (PubMed ID: 35087280)
1. The Effects of Commercially Available
Gaber M; Galal LAA; Farrag HMM; Badary DM; Alkhalil SS; Elossily N
Infect Drug Resist; 2022; 15():171-182. PubMed ID: 35087280
[TBL] [Abstract][Full Text] [Related]
2. Supplementation with Lactobacillus reuteri or L. acidophilus reduced intestinal shedding of cryptosporidium parvum oocysts in immunodeficient C57BL/6 mice.
Alak JI; Wolf BW; Mdurvwa EG; Pimentel-Smith GE; Kolavala S; Abdelrahman H; Suppiramaniam V
Cell Mol Biol (Noisy-le-grand); 1999 Sep; 45(6):855-63. PubMed ID: 10541481
[TBL] [Abstract][Full Text] [Related]
3.
Gattan HS; Wakid MH; Qahwaji RM; Altwaim S; Mahjoub HA; Alfaifi MS; Elshazly H; Al-Megrin WAI; Alshehri EA; Elshabrawy HA; El-Kady AM
Front Vet Sci; 2024; 11():1374116. PubMed ID: 38515537
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Cryptosporidium parvum infection in immunocompetent and immunocompromised mice and its role in triggering intestinal dysplasia.
Abdou AG; Harba NM; Afifi AF; Elnaidany NF
Int J Infect Dis; 2013 Aug; 17(8):e593-600. PubMed ID: 23291034
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the therapeutic efficacy of some essential oils in experimentally immunosuppressed mice infected with
Taha NM; Zalat RS; Khaled E; Elmansory BM
J Parasit Dis; 2023 Dec; 47(4):733-743. PubMed ID: 38009149
[TBL] [Abstract][Full Text] [Related]
6. Eugenol: effective complementary treatment for cryptosporidiosis in experimentally infected mice.
Gattan HS; Fouad SS; Ellisy RA; Elshazly H; El-Kady AM
J Parasit Dis; 2024 Jun; 48(2):370-380. PubMed ID: 38840881
[TBL] [Abstract][Full Text] [Related]
7. The immunomodulatory activity of secnidazole-nitazoxanide in a murine cryptosporidiosis model.
Madbouly N; El Amir A; Abdel Kader A; Rabee I; Farid A
J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33625354
[No Abstract] [Full Text] [Related]
8. Effect of nitazoxanide on cryptosporidiosis in experimentally infected neonatal dairy calves.
Ollivett TL; Nydam DV; Bowman DD; Zambriski JA; Bellosa ML; Linden TC; Divers TJ
J Dairy Sci; 2009 Apr; 92(4):1643-8. PubMed ID: 19307646
[TBL] [Abstract][Full Text] [Related]
9. Dual mechanism (sunlight/dark) of the self-assembly nitazoxanide drug on cellulose nanocrystal surface for destroying the Cryptosporidium parvum oocysts.
Khaleil SR; Mira NM; Ghanem NF; M El-Mehasseb I; Helal IB; El-Shafai NM
Int J Biol Macromol; 2023 Aug; 247():125823. PubMed ID: 37453638
[TBL] [Abstract][Full Text] [Related]
10. Garlic (Allium sativum Linnaeus) improved inflammation and reduced cryptosporidiosis burden in immunocompromised mice.
Farid A; Yousry M; Safwat G
J Ethnopharmacol; 2022 Jun; 292():115174. PubMed ID: 35259443
[TBL] [Abstract][Full Text] [Related]
11. Nitazoxanide in the treatment of cryptosporidial diarrhea and other intestinal parasitic infections associated with acquired immunodeficiency syndrome in tropical Africa.
Doumbo O; Rossignol JF; Pichard E; Traore HA; Dembele TM; Diakite M; Traore F; Diallo DA
Am J Trop Med Hyg; 1997 Jun; 56(6):637-9. PubMed ID: 9230795
[TBL] [Abstract][Full Text] [Related]
12. Assessment of chitosan nanoparticles in improving the efficacy of nitazoxanide on cryptosporidiosis in immunosuppressed and immunocompetent murine models.
Moawad HSF; Hegab MHAE; Badawey MSR; Ashoush SE; Ibrahim SM; Ali AAES
J Parasit Dis; 2021 Sep; 45(3):606-619. PubMed ID: 34475640
[TBL] [Abstract][Full Text] [Related]
13. Newly fabricated zinc oxide nanoparticles loaded materials for therapeutic nano delivery in experimental cryptosporidiosis.
Hamdy DA; Ismail MAM; El-Askary HM; Abdel-Tawab H; Ahmed MM; Fouad FM; Mohamed F
Sci Rep; 2023 Nov; 13(1):19650. PubMed ID: 37949873
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic efficacy of proton pump inhibitor (omeprazole) on cryptosporidiosis
Beshay EVN; Nassef NE; El Shafei OK; Saleh MM; Kora MA; Shalaan FH
J Parasit Dis; 2023 Sep; 47(3):535-549. PubMed ID: 37520212
[TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy of curcumin and paromomycin against Cryptosporidium parvum infection in a BALB/c model.
Asadpour M; Namazi F; Razavi SM; Nazifi S
Vet Parasitol; 2018 Jan; 250():7-14. PubMed ID: 29329627
[TBL] [Abstract][Full Text] [Related]
16. Potential effect of methanol leaf extracts from three Podocarpus species on experimental cryptosporidiosis.
El-Hawary SS; Kirollos FN; Taha KF; Dahab AA; El-Mahis AA; El-Sayed SH
Trop Biomed; 2022 Mar; 39(1):99-107. PubMed ID: 35507932
[TBL] [Abstract][Full Text] [Related]
17. [Highly Active AntiRetroviral Therapy and cryptosporidiosis].
Morales Gomez MA
Parassitologia; 2004 Jun; 46(1-2):95-9. PubMed ID: 15305695
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of nitazoxanide against Cryptosporidium parvum in cell culture and in animal models.
Theodos CM; Griffiths JK; D'Onfro J; Fairfield A; Tzipori S
Antimicrob Agents Chemother; 1998 Aug; 42(8):1959-65. PubMed ID: 9687390
[TBL] [Abstract][Full Text] [Related]
19. Role of wheat germ agglutinin (WGA) in treatment of experimental cryptosporidiosis.
Moustafa MA
J Egypt Soc Parasitol; 2003 Aug; 33(2):443-56. PubMed ID: 14964659
[TBL] [Abstract][Full Text] [Related]
20.
El-Wakil ES; Abdelmaksoud HF; Wakid MH; Alsulami MN; Hammam O; Albohiri HH; Ghallab MMI
Pharmaceuticals (Basel); 2023 Jun; 16(6):. PubMed ID: 37375825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
